CTOs on the Move

OrphoMed Inc

www.orphomed.com

 
OrphoMed is a San Francisco based clinical stage pharmaceutical company focused on the development of novel first-in-class dimer conjugates with superior therapeutic profiles. The company is leveraging its proprietary dimer platform technology to address the issues of visceral hypersensitivity and hypermotility in functional gastrointestinal disorders. OrphoMed dimers are protected by composition of matter and method of use patents.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

OrphoMed Inc raised $39M on 05/24/2017

Similar Companies

Argentis Pharmaceuticals

arGentis™ Pharmaceuticals, LLC is a private TN based pharmaceutical company with a mid-stage Orphan Drug treatment (ARG201) for late stage diffuse systemic scleroderma (dcSSc). The company is seeking capital or a partner to complete a Pivotal Clinical Trial which will enable obtaining marketing approval in the EU. The Company has a genotype marker (ROT1) that predicts patient response to treatment by oral tolerance for treatments like ARG201 for dcSSc. Furthermore, arGentis™ has a treatment for Rheumatoid arthritis (ARG301) that is in a Phase I Clinical Trial in the US.

Pharmacore

Pharmacore is a High Point, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Newport Healthcare

Newport Healthcare is changing the face of behavioral health services for teens, young adults and their families by providing sustainable healing.

isotechnika

isotechnika is a Edmonton, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.